APYX - MCAP CO - Apyx Medical

The growth of Apyx Medical (APYX) relies on the demand for plasma systems within US aesthetic medicine and FDA approval, while the financial metric stands at 0.12. Diplomatic conflicts and sanctions limit equipment exports and the certification of technologies abroad. This price chart below demonstrates the dynamics of Apyx Medical (APYX), whose electronic component supplies depend on the stability of global trade relations.

This indicator reflects the total market capitalization of all outstanding shares of Apyx Medical (APYX), allowing for a real-time assessment of the business scale. The metric is calculated as the product of the asset's current price and the number of shares, demonstrating the issuer's sensitivity to macroeconomic shocks. The current value of 0.12 serves as a benchmark for analyzing historical highs and drawdown risks. The price action of the company's total market capitalization confirms the investment attractiveness of its high-tech manufacturing in Florida. The stability of the automated assembly lines for helium systems is directly capitalized into this fundamental valuation.